2025-11

Are you considering investing in Uzbekistan, a growth market in Central Asia? Using a case study of a major project by a Chinese pharmaceutical company, an international financial journalist provides a detailed explanation of the investment environment, potential opportunities, and challenges in Uzbekistan. This information will be useful for your company's overseas strategy planning.

Forge Global's consideration of a sale signals a tipping point in the private equity market. This guide details private equity valuations, liquidity, M&A opportunities, and future investment strategies in a turbulent market.

Thermo Fisher's acquisition of Clario leads the clinical trial DX market. This guide details the strategic significance of M&A, market trends, implications for investors, and lessons to be learned by Japanese companies.